The Life Sciences Sector in Framingham and MetroWest: Today and Tomorrow

AdvaMed’s Events and Education covers the regulatory, reimbursement, legal & compliance, and sales & marketing industry environments. AdvaMed offers both members and nonmembers an [...]

Alira Health Advises Innovus Pharma in Licensing Agreement with Densmore Laboratorie

Paris, France – August 1, 2017-Innovus Pharma announced the signing of an exclusive license and distribution agreement with Densmore Pharmaceutical International for the commercialization [...]

Alira Health Advises Polylinks in Sale to Enplas

Alira Health Advises Polylinks in Sale to Enplas July 27, 2017 San Francisco, California – July 27, 2017–Enplas, a Japanese public company, acquired Polylinks, a specialized contract [...]

Alira Health and SMOC Host Summer Soccer Clinic for Framingham Children

To give children the opportunity to get in touch with nature and exercise, Alira Health partnered with SMOC and Town of Framingham Parks and Recreation to hold the first Summer Soccer Clinic. The [...]

Dr. Caitilin Hamill Joins Alira Health

Alira Health is pleased to announce that Dr. Caitilin Hamill joined the firm as a Project Manager, bringing her extensive expertise in FDA regulations to Alira Health’s clients worldwide. [...]

Dr. Martin Pöhlchen Presents Digital Transformation in Healthcare at the DVFA Life Science Conference

Martin Pöhlchen, PhD, Partner at Alira Health, Germany, will discuss the challenges and opportunities of digital transformation in healthcare at the DVFA Life Science Conference in Frankfurt am [...]

Materiomics B.V. Wins Wound Care Innovation Award

Alira Health and EWMA held their second annual Wound Care Innovation Symposium on May 4th in Amsterdam, The Netherlands. Among the presenting finalists, Dr. Bernke Papenburg, COO of Materiomics [...]

Alira Health and EWMA present the 2nd Annual Wound Care Innovation Symposium

Alira Health and EWMA are holding the 2nd Annual Wound Care Innovation Symposium during this year’s EWMA Conference in Amsterdam, Netherlands on May 4th from 3-7pm. The symposium features [...]

Alira Health’s Approach to Market Access

Alira Health’s Pharma Practice includes strategists, health economists, doctors and pharmacists to support pharmaceutical and biotechnology companies in planning and executing successful [...]

Alira Health – Your Global Partner in Healthcare and Life Science

Benjamin Chambon, Chief Operating Officer of Alira Health, and William Hariri, Director, Business Development and  Strategy Consulting, will be attending Biovision.  We have decades of experience [...]

Find your next opportunity with us at BIO-Europe Spring 17

FIND YOUR NEXT OPPORTUNITY WITH ALIRA HEALTH Alira Health’s experts would like to meet with you at BIO-Europe Spring. Whether it is commercial strategy development, health economics, [...]

David Uffer joins Alira Health

Alira Health is pleased to announce that David Uffer has joined the firm as a Partner, bringing his extensive expertise in business strategy, transaction services, and strategy execution to Alira [...]

Alira Health presents: A Novel hs-cTn Technology at ACC

Health Economics of measuring High-sensitive Cardiac Troponin at different Cut-offs in Non ST Segment Elevation Myocardial Infarction Patients with-in 6 Hours from Emergency Room Presentation [...]

Pharma Asset Deals as Smart Business Development Strategy

Despite the fairly stable number of asset deals per year, their accumulated value significantly increased from 2010 and 2015, showing positive momentum for this type of transaction. Importantly, [...]

Where the Brightest Minds in Health & IT Meet

Alira Health is pleased to announce their team’s attendance at HIMSS 17. The 2017 HIMSS Annual Conference & Exhibition brings together 40,000+ health IT professionals, clinicians, [...]

Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma

  Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma February 6, 2017 Paris, France – February 6, 2017 – Ipsen announced that it has signed an agreement to take an [...]

CMC Consulting Group Becomes Alira Health

New name reflects dramatic expansion to include innovative research, product development, and business incubator Our New Identity Boston, USA and Paris, France — January 9, 2017 CMC Consulting [...]

CMC Consulting Group Announces Planned Name Change to Alira Health

CMC Consulting Group (www.cmc-co.net) is pleased to announce its new name, Alira Health, effective January 1, 2017. The company’s decision reflects the continuing evolution of its advisory, [...]

CMC Consulting Group Celebrates the Medical Affairs Division’s 1-Year Anniversary

Boston, Massachusetts — CMC Consulting Group, an international healthcare advisory firm, has announced its Medical Affairs Division’s (MAD) one-year anniversary. Since their October 2014 [...]

CMC Advised MNH in the Acquisition of Groupe Profession Santé

CMC Advised MNH in the Acquisition of Groupe Profession Santé September 5, 2016 Paris, September 5, 2016 – Mutuelle Nationale des Hospitaliers (MNH) acquired the majority stake in Groupe [...]

Gabriele Brambilla Closes Harvard vs MIT Case Competition as Keynote Speaker

(Cambridge, MA) Gabriele Brambilla, CEO of CMC Consulting Group, was the keynote speaker for the closing reception at the Harvard vs MIT Case Competition. In his speech, he gave a panoramic view [...]

CMC Advises LaunchWorks Manufacturing Lab in its sale to TCP Reliable

TCP Reliable purchased the assets of LaunchWorks Manufacturing Lab, an ISO 13485 certified contract manufacturing organization and provider of supply chain solutions.  Prior to the transaction, [...]

Imbed Biosciences Inc. Wins the Wound Care Innovation Award at CMC and EWMA’s First Annual Symposium

BREMEN, GERMANY – CMC and EWMA held their first annual Wound Care Innovation Symposium on May 12th in Bremen, Germany. Among the presenting finalists, Imbed Biosciences Inc. was awarded the [...]

Next Generation Sequencing (NGS) for Infectious Disease Diagnostics: An Opportunity for Growth

Regulatory Affairs: How understanding the current FDA processes will shape the future of your medical device

CMC Advises Mitim Srl in the Sale to Recipharm

  CMC Advises Mitim Srl in the Sale to Recipharm February 25, 2016   Milan – Recipharm AB today announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl [...]

CMC Advises Delta Med in the Sale to Augens Capital and DB Private Equity

Milan – Eukedos S.p.A. and Augens Capital announce the signature of a definitive agreement for Augeo 1 S.r.l., an investment vehicle affiliated with Augens Capital, to acquire Delta Med S.p.A. [...]

CMC Consulting Group Hosted 2nd M&A and Innovation in Healthcare Event

The afternoon long conference brought together over 90 leaders in healthcare innovation including clinical experts, distinguished academics, financial investors, and corporates who discussed the [...]

CMC Advises Keosys on sale of a majority stake to JMC Investment

CMC Advises Keosys on sale of a majority stake to JMC Investment September 15, 2015 Paris, France –  CMC congratulates its client, Keosys on the sale of a majority stake of the company to [...]

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia April 14, 2015 Paris, France – Lavorel Groupe announced the acquisition of LTDAS Apotecnia through their subsidiary [...]

CMC Advises Sidam on Sale to Synopo

CMC Advises Sidam on Sale to Synopo March 3, 2015 Milan, Italy – CMC congratulates its client, Sidam S.r.l.  on the sale of the company to Synopo S.p.A.  Founded in 1991, Sidam manufactures [...]

CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services

  CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services February 8, 2015 Boston, MA – CMC Transaction Services, the life science focused investment bank, [...]

CMC Advises CutisPharma on Equity Financing

CMC Advises CutisPharma on Equity Financing January 15, 2015 Boston, MA – Johnston Blakely & Company, a CMC Group company, congratulates its client, CutisPharma, Inc., on its [...]

The Life Sciences Sector in Framingham and MetroWest: Today and Tomorrow

AdvaMed’s Events and Education covers the regulatory, reimbursement, legal & compliance, and sales & marketing industry environments. AdvaMed offers both members and nonmembers an [...]

Alira Health Advises Innovus Pharma in Licensing Agreement with Densmore Laboratorie

Paris, France – August 1, 2017-Innovus Pharma announced the signing of an exclusive license and distribution agreement with Densmore Pharmaceutical International for the commercialization [...]

Alira Health Advises Polylinks in Sale to Enplas

Alira Health Advises Polylinks in Sale to Enplas July 27, 2017 San Francisco, California – July 27, 2017–Enplas, a Japanese public company, acquired Polylinks, a specialized contract [...]

Alira Health and SMOC Host Summer Soccer Clinic for Framingham Children

To give children the opportunity to get in touch with nature and exercise, Alira Health partnered with SMOC and Town of Framingham Parks and Recreation to hold the first Summer Soccer Clinic. The [...]

Dr. Caitilin Hamill Joins Alira Health

Alira Health is pleased to announce that Dr. Caitilin Hamill joined the firm as a Project Manager, bringing her extensive expertise in FDA regulations to Alira Health’s clients worldwide. [...]

Dr. Martin Pöhlchen Presents Digital Transformation in Healthcare at the DVFA Life Science Conference

Martin Pöhlchen, PhD, Partner at Alira Health, Germany, will discuss the challenges and opportunities of digital transformation in healthcare at the DVFA Life Science Conference in Frankfurt am [...]

Materiomics B.V. Wins Wound Care Innovation Award

Alira Health and EWMA held their second annual Wound Care Innovation Symposium on May 4th in Amsterdam, The Netherlands. Among the presenting finalists, Dr. Bernke Papenburg, COO of Materiomics [...]

Alira Health and EWMA present the 2nd Annual Wound Care Innovation Symposium

Alira Health and EWMA are holding the 2nd Annual Wound Care Innovation Symposium during this year’s EWMA Conference in Amsterdam, Netherlands on May 4th from 3-7pm. The symposium features [...]

Alira Health’s Approach to Market Access

Alira Health’s Pharma Practice includes strategists, health economists, doctors and pharmacists to support pharmaceutical and biotechnology companies in planning and executing successful [...]

Alira Health – Your Global Partner in Healthcare and Life Science

Benjamin Chambon, Chief Operating Officer of Alira Health, and William Hariri, Director, Business Development and  Strategy Consulting, will be attending Biovision.  We have decades of experience [...]

Find your next opportunity with us at BIO-Europe Spring 17

FIND YOUR NEXT OPPORTUNITY WITH ALIRA HEALTH Alira Health’s experts would like to meet with you at BIO-Europe Spring. Whether it is commercial strategy development, health economics, [...]

David Uffer joins Alira Health

Alira Health is pleased to announce that David Uffer has joined the firm as a Partner, bringing his extensive expertise in business strategy, transaction services, and strategy execution to Alira [...]

Alira Health presents: A Novel hs-cTn Technology at ACC

Health Economics of measuring High-sensitive Cardiac Troponin at different Cut-offs in Non ST Segment Elevation Myocardial Infarction Patients with-in 6 Hours from Emergency Room Presentation [...]

Pharma Asset Deals as Smart Business Development Strategy

Despite the fairly stable number of asset deals per year, their accumulated value significantly increased from 2010 and 2015, showing positive momentum for this type of transaction. Importantly, [...]

Where the Brightest Minds in Health & IT Meet

Alira Health is pleased to announce their team’s attendance at HIMSS 17. The 2017 HIMSS Annual Conference & Exhibition brings together 40,000+ health IT professionals, clinicians, [...]

Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma

  Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma February 6, 2017 Paris, France – February 6, 2017 – Ipsen announced that it has signed an agreement to take an [...]

CMC Consulting Group Becomes Alira Health

New name reflects dramatic expansion to include innovative research, product development, and business incubator Our New Identity Boston, USA and Paris, France — January 9, 2017 CMC Consulting [...]

CMC Consulting Group Announces Planned Name Change to Alira Health

CMC Consulting Group (www.cmc-co.net) is pleased to announce its new name, Alira Health, effective January 1, 2017. The company’s decision reflects the continuing evolution of its advisory, [...]

CMC Consulting Group Celebrates the Medical Affairs Division’s 1-Year Anniversary

Boston, Massachusetts — CMC Consulting Group, an international healthcare advisory firm, has announced its Medical Affairs Division’s (MAD) one-year anniversary. Since their October 2014 [...]

CMC Advised MNH in the Acquisition of Groupe Profession Santé

CMC Advised MNH in the Acquisition of Groupe Profession Santé September 5, 2016 Paris, September 5, 2016 – Mutuelle Nationale des Hospitaliers (MNH) acquired the majority stake in Groupe [...]

Gabriele Brambilla Closes Harvard vs MIT Case Competition as Keynote Speaker

(Cambridge, MA) Gabriele Brambilla, CEO of CMC Consulting Group, was the keynote speaker for the closing reception at the Harvard vs MIT Case Competition. In his speech, he gave a panoramic view [...]

CMC Advises LaunchWorks Manufacturing Lab in its sale to TCP Reliable

TCP Reliable purchased the assets of LaunchWorks Manufacturing Lab, an ISO 13485 certified contract manufacturing organization and provider of supply chain solutions.  Prior to the transaction, [...]

Imbed Biosciences Inc. Wins the Wound Care Innovation Award at CMC and EWMA’s First Annual Symposium

BREMEN, GERMANY – CMC and EWMA held their first annual Wound Care Innovation Symposium on May 12th in Bremen, Germany. Among the presenting finalists, Imbed Biosciences Inc. was awarded the [...]

Next Generation Sequencing (NGS) for Infectious Disease Diagnostics: An Opportunity for Growth

Regulatory Affairs: How understanding the current FDA processes will shape the future of your medical device

CMC Advises Mitim Srl in the Sale to Recipharm

  CMC Advises Mitim Srl in the Sale to Recipharm February 25, 2016   Milan – Recipharm AB today announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl [...]

CMC Advises Delta Med in the Sale to Augens Capital and DB Private Equity

Milan – Eukedos S.p.A. and Augens Capital announce the signature of a definitive agreement for Augeo 1 S.r.l., an investment vehicle affiliated with Augens Capital, to acquire Delta Med S.p.A. [...]

CMC Consulting Group Hosted 2nd M&A and Innovation in Healthcare Event

The afternoon long conference brought together over 90 leaders in healthcare innovation including clinical experts, distinguished academics, financial investors, and corporates who discussed the [...]

CMC Advises Keosys on sale of a majority stake to JMC Investment

CMC Advises Keosys on sale of a majority stake to JMC Investment September 15, 2015 Paris, France –  CMC congratulates its client, Keosys on the sale of a majority stake of the company to [...]

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia April 14, 2015 Paris, France – Lavorel Groupe announced the acquisition of LTDAS Apotecnia through their subsidiary [...]

CMC Advises Sidam on Sale to Synopo

CMC Advises Sidam on Sale to Synopo March 3, 2015 Milan, Italy – CMC congratulates its client, Sidam S.r.l.  on the sale of the company to Synopo S.p.A.  Founded in 1991, Sidam manufactures [...]

CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services

  CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services February 8, 2015 Boston, MA – CMC Transaction Services, the life science focused investment bank, [...]

CMC Advises CutisPharma on Equity Financing

CMC Advises CutisPharma on Equity Financing January 15, 2015 Boston, MA – Johnston Blakely & Company, a CMC Group company, congratulates its client, CutisPharma, Inc., on its [...]

The Life Sciences Sector in Framingham and MetroWest: Today and Tomorrow

AdvaMed’s Events and Education covers the regulatory, reimbursement, legal & compliance, and sales & marketing industry environments. AdvaMed offers both members and nonmembers an [...]

Alira Health Advises Innovus Pharma in Licensing Agreement with Densmore Laboratorie

Paris, France – August 1, 2017-Innovus Pharma announced the signing of an exclusive license and distribution agreement with Densmore Pharmaceutical International for the commercialization [...]

Alira Health Advises Polylinks in Sale to Enplas

Alira Health Advises Polylinks in Sale to Enplas July 27, 2017 San Francisco, California – July 27, 2017–Enplas, a Japanese public company, acquired Polylinks, a specialized contract [...]

Alira Health and SMOC Host Summer Soccer Clinic for Framingham Children

To give children the opportunity to get in touch with nature and exercise, Alira Health partnered with SMOC and Town of Framingham Parks and Recreation to hold the first Summer Soccer Clinic. The [...]

Dr. Caitilin Hamill Joins Alira Health

Alira Health is pleased to announce that Dr. Caitilin Hamill joined the firm as a Project Manager, bringing her extensive expertise in FDA regulations to Alira Health’s clients worldwide. [...]

Dr. Martin Pöhlchen Presents Digital Transformation in Healthcare at the DVFA Life Science Conference

Martin Pöhlchen, PhD, Partner at Alira Health, Germany, will discuss the challenges and opportunities of digital transformation in healthcare at the DVFA Life Science Conference in Frankfurt am [...]

Materiomics B.V. Wins Wound Care Innovation Award

Alira Health and EWMA held their second annual Wound Care Innovation Symposium on May 4th in Amsterdam, The Netherlands. Among the presenting finalists, Dr. Bernke Papenburg, COO of Materiomics [...]

Alira Health and EWMA present the 2nd Annual Wound Care Innovation Symposium

Alira Health and EWMA are holding the 2nd Annual Wound Care Innovation Symposium during this year’s EWMA Conference in Amsterdam, Netherlands on May 4th from 3-7pm. The symposium features [...]

Alira Health’s Approach to Market Access

Alira Health’s Pharma Practice includes strategists, health economists, doctors and pharmacists to support pharmaceutical and biotechnology companies in planning and executing successful [...]

Alira Health – Your Global Partner in Healthcare and Life Science

Benjamin Chambon, Chief Operating Officer of Alira Health, and William Hariri, Director, Business Development and  Strategy Consulting, will be attending Biovision.  We have decades of experience [...]

Find your next opportunity with us at BIO-Europe Spring 17

FIND YOUR NEXT OPPORTUNITY WITH ALIRA HEALTH Alira Health’s experts would like to meet with you at BIO-Europe Spring. Whether it is commercial strategy development, health economics, [...]

David Uffer joins Alira Health

Alira Health is pleased to announce that David Uffer has joined the firm as a Partner, bringing his extensive expertise in business strategy, transaction services, and strategy execution to Alira [...]

Alira Health presents: A Novel hs-cTn Technology at ACC

Health Economics of measuring High-sensitive Cardiac Troponin at different Cut-offs in Non ST Segment Elevation Myocardial Infarction Patients with-in 6 Hours from Emergency Room Presentation [...]

Pharma Asset Deals as Smart Business Development Strategy

Despite the fairly stable number of asset deals per year, their accumulated value significantly increased from 2010 and 2015, showing positive momentum for this type of transaction. Importantly, [...]

Where the Brightest Minds in Health & IT Meet

Alira Health is pleased to announce their team’s attendance at HIMSS 17. The 2017 HIMSS Annual Conference & Exhibition brings together 40,000+ health IT professionals, clinicians, [...]

Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma

  Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma February 6, 2017 Paris, France – February 6, 2017 – Ipsen announced that it has signed an agreement to take an [...]

CMC Consulting Group Becomes Alira Health

New name reflects dramatic expansion to include innovative research, product development, and business incubator Our New Identity Boston, USA and Paris, France — January 9, 2017 CMC Consulting [...]

CMC Consulting Group Announces Planned Name Change to Alira Health

CMC Consulting Group (www.cmc-co.net) is pleased to announce its new name, Alira Health, effective January 1, 2017. The company’s decision reflects the continuing evolution of its advisory, [...]

CMC Consulting Group Celebrates the Medical Affairs Division’s 1-Year Anniversary

Boston, Massachusetts — CMC Consulting Group, an international healthcare advisory firm, has announced its Medical Affairs Division’s (MAD) one-year anniversary. Since their October 2014 [...]

CMC Advised MNH in the Acquisition of Groupe Profession Santé

CMC Advised MNH in the Acquisition of Groupe Profession Santé September 5, 2016 Paris, September 5, 2016 – Mutuelle Nationale des Hospitaliers (MNH) acquired the majority stake in Groupe [...]

Gabriele Brambilla Closes Harvard vs MIT Case Competition as Keynote Speaker

(Cambridge, MA) Gabriele Brambilla, CEO of CMC Consulting Group, was the keynote speaker for the closing reception at the Harvard vs MIT Case Competition. In his speech, he gave a panoramic view [...]

CMC Advises LaunchWorks Manufacturing Lab in its sale to TCP Reliable

TCP Reliable purchased the assets of LaunchWorks Manufacturing Lab, an ISO 13485 certified contract manufacturing organization and provider of supply chain solutions.  Prior to the transaction, [...]

Imbed Biosciences Inc. Wins the Wound Care Innovation Award at CMC and EWMA’s First Annual Symposium

BREMEN, GERMANY – CMC and EWMA held their first annual Wound Care Innovation Symposium on May 12th in Bremen, Germany. Among the presenting finalists, Imbed Biosciences Inc. was awarded the [...]

Next Generation Sequencing (NGS) for Infectious Disease Diagnostics: An Opportunity for Growth

New 3D Printed Biofilm Models for Studying Multispecies Bacterial Communities

Regulatory Affairs: How understanding the current FDA processes will shape the future of your medical device

CMC Advises Mitim Srl in the Sale to Recipharm

  CMC Advises Mitim Srl in the Sale to Recipharm February 25, 2016   Milan – Recipharm AB today announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl [...]

CMC Advises Delta Med in the Sale to Augens Capital and DB Private Equity

Milan – Eukedos S.p.A. and Augens Capital announce the signature of a definitive agreement for Augeo 1 S.r.l., an investment vehicle affiliated with Augens Capital, to acquire Delta Med S.p.A. [...]

CMC Consulting Group Hosted 2nd M&A and Innovation in Healthcare Event

The afternoon long conference brought together over 90 leaders in healthcare innovation including clinical experts, distinguished academics, financial investors, and corporates who discussed the [...]

CMC Advises Keosys on sale of a majority stake to JMC Investment

CMC Advises Keosys on sale of a majority stake to JMC Investment September 15, 2015 Paris, France –  CMC congratulates its client, Keosys on the sale of a majority stake of the company to [...]

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia April 14, 2015 Paris, France – Lavorel Groupe announced the acquisition of LTDAS Apotecnia through their subsidiary [...]

CMC Advises Sidam on Sale to Synopo

CMC Advises Sidam on Sale to Synopo March 3, 2015 Milan, Italy – CMC congratulates its client, Sidam S.r.l.  on the sale of the company to Synopo S.p.A.  Founded in 1991, Sidam manufactures [...]

CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services

  CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services February 8, 2015 Boston, MA – CMC Transaction Services, the life science focused investment bank, [...]

CMC Advises CutisPharma on Equity Financing

CMC Advises CutisPharma on Equity Financing January 15, 2015 Boston, MA – Johnston Blakely & Company, a CMC Group company, congratulates its client, CutisPharma, Inc., on its [...]

The Life Sciences Sector in Framingham and MetroWest: Today and Tomorrow

AdvaMed’s Events and Education covers the regulatory, reimbursement, legal & compliance, and sales & marketing industry environments. AdvaMed offers both members and nonmembers an [...]

Alira Health Advises Innovus Pharma in Licensing Agreement with Densmore Laboratorie

Paris, France – August 1, 2017-Innovus Pharma announced the signing of an exclusive license and distribution agreement with Densmore Pharmaceutical International for the commercialization [...]

Alira Health Advises Polylinks in Sale to Enplas

Alira Health Advises Polylinks in Sale to Enplas July 27, 2017 San Francisco, California – July 27, 2017–Enplas, a Japanese public company, acquired Polylinks, a specialized contract [...]

Alira Health and SMOC Host Summer Soccer Clinic for Framingham Children

To give children the opportunity to get in touch with nature and exercise, Alira Health partnered with SMOC and Town of Framingham Parks and Recreation to hold the first Summer Soccer Clinic. The [...]

Dr. Caitilin Hamill Joins Alira Health

Alira Health is pleased to announce that Dr. Caitilin Hamill joined the firm as a Project Manager, bringing her extensive expertise in FDA regulations to Alira Health’s clients worldwide. [...]

Dr. Martin Pöhlchen Presents Digital Transformation in Healthcare at the DVFA Life Science Conference

Martin Pöhlchen, PhD, Partner at Alira Health, Germany, will discuss the challenges and opportunities of digital transformation in healthcare at the DVFA Life Science Conference in Frankfurt am [...]

Materiomics B.V. Wins Wound Care Innovation Award

Alira Health and EWMA held their second annual Wound Care Innovation Symposium on May 4th in Amsterdam, The Netherlands. Among the presenting finalists, Dr. Bernke Papenburg, COO of Materiomics [...]

Alira Health and EWMA present the 2nd Annual Wound Care Innovation Symposium

Alira Health and EWMA are holding the 2nd Annual Wound Care Innovation Symposium during this year’s EWMA Conference in Amsterdam, Netherlands on May 4th from 3-7pm. The symposium features [...]

Alira Health’s Approach to Market Access

Alira Health’s Pharma Practice includes strategists, health economists, doctors and pharmacists to support pharmaceutical and biotechnology companies in planning and executing successful [...]

Alira Health – Your Global Partner in Healthcare and Life Science

Benjamin Chambon, Chief Operating Officer of Alira Health, and William Hariri, Director, Business Development and  Strategy Consulting, will be attending Biovision.  We have decades of experience [...]

Find your next opportunity with us at BIO-Europe Spring 17

FIND YOUR NEXT OPPORTUNITY WITH ALIRA HEALTH Alira Health’s experts would like to meet with you at BIO-Europe Spring. Whether it is commercial strategy development, health economics, [...]

David Uffer joins Alira Health

Alira Health is pleased to announce that David Uffer has joined the firm as a Partner, bringing his extensive expertise in business strategy, transaction services, and strategy execution to Alira [...]

Alira Health presents: A Novel hs-cTn Technology at ACC

Health Economics of measuring High-sensitive Cardiac Troponin at different Cut-offs in Non ST Segment Elevation Myocardial Infarction Patients with-in 6 Hours from Emergency Room Presentation [...]

Pharma Asset Deals as Smart Business Development Strategy

Despite the fairly stable number of asset deals per year, their accumulated value significantly increased from 2010 and 2015, showing positive momentum for this type of transaction. Importantly, [...]

Where the Brightest Minds in Health & IT Meet

Alira Health is pleased to announce their team’s attendance at HIMSS 17. The 2017 HIMSS Annual Conference & Exhibition brings together 40,000+ health IT professionals, clinicians, [...]

Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma

  Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma February 6, 2017 Paris, France – February 6, 2017 – Ipsen announced that it has signed an agreement to take an [...]

CMC Consulting Group Becomes Alira Health

New name reflects dramatic expansion to include innovative research, product development, and business incubator Our New Identity Boston, USA and Paris, France — January 9, 2017 CMC Consulting [...]

CMC Consulting Group Announces Planned Name Change to Alira Health

CMC Consulting Group (www.cmc-co.net) is pleased to announce its new name, Alira Health, effective January 1, 2017. The company’s decision reflects the continuing evolution of its advisory, [...]

CMC Consulting Group Celebrates the Medical Affairs Division’s 1-Year Anniversary

Boston, Massachusetts — CMC Consulting Group, an international healthcare advisory firm, has announced its Medical Affairs Division’s (MAD) one-year anniversary. Since their October 2014 [...]

CMC Advised MNH in the Acquisition of Groupe Profession Santé

CMC Advised MNH in the Acquisition of Groupe Profession Santé September 5, 2016 Paris, September 5, 2016 – Mutuelle Nationale des Hospitaliers (MNH) acquired the majority stake in Groupe [...]

Gabriele Brambilla Closes Harvard vs MIT Case Competition as Keynote Speaker

(Cambridge, MA) Gabriele Brambilla, CEO of CMC Consulting Group, was the keynote speaker for the closing reception at the Harvard vs MIT Case Competition. In his speech, he gave a panoramic view [...]

CMC Advises LaunchWorks Manufacturing Lab in its sale to TCP Reliable

TCP Reliable purchased the assets of LaunchWorks Manufacturing Lab, an ISO 13485 certified contract manufacturing organization and provider of supply chain solutions.  Prior to the transaction, [...]

Imbed Biosciences Inc. Wins the Wound Care Innovation Award at CMC and EWMA’s First Annual Symposium

BREMEN, GERMANY – CMC and EWMA held their first annual Wound Care Innovation Symposium on May 12th in Bremen, Germany. Among the presenting finalists, Imbed Biosciences Inc. was awarded the [...]

Next Generation Sequencing (NGS) for Infectious Disease Diagnostics: An Opportunity for Growth

New 3D Printed Biofilm Models for Studying Multispecies Bacterial Communities

Regulatory Affairs: How understanding the current FDA processes will shape the future of your medical device

CMC Advises Mitim Srl in the Sale to Recipharm

  CMC Advises Mitim Srl in the Sale to Recipharm February 25, 2016   Milan – Recipharm AB today announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl [...]

CMC Advises Delta Med in the Sale to Augens Capital and DB Private Equity

Milan – Eukedos S.p.A. and Augens Capital announce the signature of a definitive agreement for Augeo 1 S.r.l., an investment vehicle affiliated with Augens Capital, to acquire Delta Med S.p.A. [...]

CMC Consulting Group Hosted 2nd M&A and Innovation in Healthcare Event

The afternoon long conference brought together over 90 leaders in healthcare innovation including clinical experts, distinguished academics, financial investors, and corporates who discussed the [...]

CMC Advises Keosys on sale of a majority stake to JMC Investment

CMC Advises Keosys on sale of a majority stake to JMC Investment September 15, 2015 Paris, France –  CMC congratulates its client, Keosys on the sale of a majority stake of the company to [...]

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia April 14, 2015 Paris, France – Lavorel Groupe announced the acquisition of LTDAS Apotecnia through their subsidiary [...]

CMC Advises Sidam on Sale to Synopo

CMC Advises Sidam on Sale to Synopo March 3, 2015 Milan, Italy – CMC congratulates its client, Sidam S.r.l.  on the sale of the company to Synopo S.p.A.  Founded in 1991, Sidam manufactures [...]

CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services

  CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services February 8, 2015 Boston, MA – CMC Transaction Services, the life science focused investment bank, [...]

CMC Advises CutisPharma on Equity Financing

CMC Advises CutisPharma on Equity Financing January 15, 2015 Boston, MA – Johnston Blakely & Company, a CMC Group company, congratulates its client, CutisPharma, Inc., on its [...]

News Center

The Life Sciences Sector in Framingham and MetroWest: Today and Tomorrow

AdvaMed’s Events and Education covers the regulatory, reimbursement, legal & compliance, and sales & marketing industry environments. AdvaMed offers both members and nonmembers an [...]

Alira Health Advises Innovus Pharma in Licensing Agreement with Densmore Laboratorie

Paris, France – August 1, 2017-Innovus Pharma announced the signing of an exclusive license and distribution agreement with Densmore Pharmaceutical International for the commercialization [...]

Alira Health Advises Polylinks in Sale to Enplas

Alira Health Advises Polylinks in Sale to Enplas July 27, 2017 San Francisco, California – July 27, 2017–Enplas, a Japanese public company, acquired Polylinks, a specialized contract [...]

Alira Health and SMOC Host Summer Soccer Clinic for Framingham Children

To give children the opportunity to get in touch with nature and exercise, Alira Health partnered with SMOC and Town of Framingham Parks and Recreation to hold the first Summer Soccer Clinic. The [...]

Dr. Caitilin Hamill Joins Alira Health

Alira Health is pleased to announce that Dr. Caitilin Hamill joined the firm as a Project Manager, bringing her extensive expertise in FDA regulations to Alira Health’s clients worldwide. [...]

Dr. Martin Pöhlchen Presents Digital Transformation in Healthcare at the DVFA Life Science Conference

Martin Pöhlchen, PhD, Partner at Alira Health, Germany, will discuss the challenges and opportunities of digital transformation in healthcare at the DVFA Life Science Conference in Frankfurt am [...]

Materiomics B.V. Wins Wound Care Innovation Award

Alira Health and EWMA held their second annual Wound Care Innovation Symposium on May 4th in Amsterdam, The Netherlands. Among the presenting finalists, Dr. Bernke Papenburg, COO of Materiomics [...]

Alira Health and EWMA present the 2nd Annual Wound Care Innovation Symposium

Alira Health and EWMA are holding the 2nd Annual Wound Care Innovation Symposium during this year’s EWMA Conference in Amsterdam, Netherlands on May 4th from 3-7pm. The symposium features [...]

Alira Health’s Approach to Market Access

Alira Health’s Pharma Practice includes strategists, health economists, doctors and pharmacists to support pharmaceutical and biotechnology companies in planning and executing successful [...]

Alira Health – Your Global Partner in Healthcare and Life Science

Benjamin Chambon, Chief Operating Officer of Alira Health, and William Hariri, Director, Business Development and  Strategy Consulting, will be attending Biovision.  We have decades of experience [...]

Find your next opportunity with us at BIO-Europe Spring 17

FIND YOUR NEXT OPPORTUNITY WITH ALIRA HEALTH Alira Health’s experts would like to meet with you at BIO-Europe Spring. Whether it is commercial strategy development, health economics, [...]

David Uffer joins Alira Health

Alira Health is pleased to announce that David Uffer has joined the firm as a Partner, bringing his extensive expertise in business strategy, transaction services, and strategy execution to Alira [...]

Alira Health presents: A Novel hs-cTn Technology at ACC

Health Economics of measuring High-sensitive Cardiac Troponin at different Cut-offs in Non ST Segment Elevation Myocardial Infarction Patients with-in 6 Hours from Emergency Room Presentation [...]

Pharma Asset Deals as Smart Business Development Strategy

Despite the fairly stable number of asset deals per year, their accumulated value significantly increased from 2010 and 2015, showing positive momentum for this type of transaction. Importantly, [...]

Where the Brightest Minds in Health & IT Meet

Alira Health is pleased to announce their team’s attendance at HIMSS 17. The 2017 HIMSS Annual Conference & Exhibition brings together 40,000+ health IT professionals, clinicians, [...]

Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma

  Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma February 6, 2017 Paris, France – February 6, 2017 – Ipsen announced that it has signed an agreement to take an [...]

CMC Consulting Group Becomes Alira Health

New name reflects dramatic expansion to include innovative research, product development, and business incubator Our New Identity Boston, USA and Paris, France — January 9, 2017 CMC Consulting [...]

CMC Consulting Group Announces Planned Name Change to Alira Health

CMC Consulting Group (www.cmc-co.net) is pleased to announce its new name, Alira Health, effective January 1, 2017. The company’s decision reflects the continuing evolution of its advisory, [...]

CMC Consulting Group Celebrates the Medical Affairs Division’s 1-Year Anniversary

Boston, Massachusetts — CMC Consulting Group, an international healthcare advisory firm, has announced its Medical Affairs Division’s (MAD) one-year anniversary. Since their October 2014 [...]

CMC Advised MNH in the Acquisition of Groupe Profession Santé

CMC Advised MNH in the Acquisition of Groupe Profession Santé September 5, 2016 Paris, September 5, 2016 – Mutuelle Nationale des Hospitaliers (MNH) acquired the majority stake in Groupe [...]

Gabriele Brambilla Closes Harvard vs MIT Case Competition as Keynote Speaker

(Cambridge, MA) Gabriele Brambilla, CEO of CMC Consulting Group, was the keynote speaker for the closing reception at the Harvard vs MIT Case Competition. In his speech, he gave a panoramic view [...]

CMC Advises LaunchWorks Manufacturing Lab in its sale to TCP Reliable

TCP Reliable purchased the assets of LaunchWorks Manufacturing Lab, an ISO 13485 certified contract manufacturing organization and provider of supply chain solutions.  Prior to the transaction, [...]

Imbed Biosciences Inc. Wins the Wound Care Innovation Award at CMC and EWMA’s First Annual Symposium

BREMEN, GERMANY – CMC and EWMA held their first annual Wound Care Innovation Symposium on May 12th in Bremen, Germany. Among the presenting finalists, Imbed Biosciences Inc. was awarded the [...]

Next Generation Sequencing (NGS) for Infectious Disease Diagnostics: An Opportunity for Growth

New 3D Printed Biofilm Models for Studying Multispecies Bacterial Communities

Regulatory Affairs: How understanding the current FDA processes will shape the future of your medical device

CMC Advises Mitim Srl in the Sale to Recipharm

  CMC Advises Mitim Srl in the Sale to Recipharm February 25, 2016   Milan – Recipharm AB today announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl [...]

CMC Advises Delta Med in the Sale to Augens Capital and DB Private Equity

Milan – Eukedos S.p.A. and Augens Capital announce the signature of a definitive agreement for Augeo 1 S.r.l., an investment vehicle affiliated with Augens Capital, to acquire Delta Med S.p.A. [...]

CMC Consulting Group Hosted 2nd M&A and Innovation in Healthcare Event

The afternoon long conference brought together over 90 leaders in healthcare innovation including clinical experts, distinguished academics, financial investors, and corporates who discussed the [...]

CMC Advises Keosys on sale of a majority stake to JMC Investment

CMC Advises Keosys on sale of a majority stake to JMC Investment September 15, 2015 Paris, France –  CMC congratulates its client, Keosys on the sale of a majority stake of the company to [...]

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia April 14, 2015 Paris, France – Lavorel Groupe announced the acquisition of LTDAS Apotecnia through their subsidiary [...]

CMC Advises Sidam on Sale to Synopo

CMC Advises Sidam on Sale to Synopo March 3, 2015 Milan, Italy – CMC congratulates its client, Sidam S.r.l.  on the sale of the company to Synopo S.p.A.  Founded in 1991, Sidam manufactures [...]

CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services

  CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services February 8, 2015 Boston, MA – CMC Transaction Services, the life science focused investment bank, [...]

CMC Advises CutisPharma on Equity Financing

CMC Advises CutisPharma on Equity Financing January 15, 2015 Boston, MA – Johnston Blakely & Company, a CMC Group company, congratulates its client, CutisPharma, Inc., on its [...]